Dan Ollendorf, PhD

Chief Scientific Officer
Institute for Clinical and Economic Review

Dan is Chief Scientific Officer for the Institute of Clinical and Economic Review (ICER); in this capacity, he is responsible for the conduct of systematic reviews of the comparative effectiveness of new or emerging health care technologies as well as assessments of their potential cost-effectiveness and budgetary impact, and coordination and oversight of the broader health technology assessment process. Dan’s 30 years of health care experience include work in the insurance, managed care, hospital, informatics, and consulting sectors, the last 20 years of which have been spent conducting health-economic, epidemiologic, and other relevant evaluations for a variety of stakeholders.

Dan holds a PhD in clinical epidemiology from the University of Amsterdam (Netherlands), a Master’s of Public Health in epidemiology/biostatistics and health services from Boston University, and a Bachelor of Arts in Health Administration from the University of Rochester. He has authored over 50 peer-reviewed articles in major medical journals. Dan is a member of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) and of the scientific review group of Health Technology Assessment International (HTAi).